Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Phenytoin and Itraconazole on BGB-58067 Pharmacokinetics in Healthy Participants
NCT07590102Phase 1Recruiting
- Sponsor
- BeOne Medicines
- Start
- Jun 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of BGB-58067 (2 arms), sponsored by BeOne Medicines. Primary endpoints: Time of the Maximum Observed Concentration at Day 18, Maximum Observed Concentration at Day 18 and 5 more. Started Jun 2026; status: recruiting.
02
Drugs
BGB-58067
Beyond the preview
Go deeper on NCT07590102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07590102.